A detailed history of Kennedy Capital Management, Inc. transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 373,397 shares of CDMO stock, worth $4.59 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
373,397
Previous 581,237 35.76%
Holding current value
$4.59 Million
Previous $4.15 Million 2.39%
% of portfolio
0.1%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.7 - $12.45 $1.39 Million - $2.59 Million
-207,840 Reduced 35.76%
373,397 $4.25 Million
Q2 2024

Aug 14, 2024

SELL
$6.34 - $9.28 $100,501 - $147,106
-15,852 Reduced 2.65%
581,237 $4.15 Million
Q1 2024

May 15, 2024

BUY
$5.86 - $8.79 $1.5 Million - $2.24 Million
255,201 Added 74.64%
597,089 $4 Million
Q4 2023

Feb 14, 2024

SELL
$4.64 - $9.56 $78,211 - $161,143
-16,856 Reduced 4.7%
341,888 $2.22 Million
Q3 2023

Nov 14, 2023

SELL
$9.4 - $14.04 $211,829 - $316,391
-22,535 Reduced 5.91%
358,744 $3.39 Million
Q2 2023

Aug 14, 2023

BUY
$12.96 - $20.93 $2.42 Million - $3.91 Million
186,850 Added 96.1%
381,279 $5.33 Million
Q1 2023

May 15, 2023

BUY
$13.48 - $18.79 $50,927 - $70,988
3,778 Added 1.98%
194,429 $3.65 Million
Q4 2022

Feb 14, 2023

SELL
$12.61 - $18.74 $1.04 Million - $1.54 Million
-82,262 Reduced 30.14%
190,651 $2.63 Million
Q3 2022

Nov 14, 2022

SELL
$15.33 - $20.36 $3,219 - $4,275
-210 Reduced 0.08%
272,913 $5.22 Million
Q2 2022

Aug 10, 2022

BUY
$11.63 - $21.55 $379,870 - $703,887
32,663 Added 13.58%
273,123 $4.17 Million
Q1 2022

May 16, 2022

BUY
$16.63 - $27.73 $2.05 Million - $3.42 Million
123,409 Added 105.43%
240,460 $4.9 Million
Q4 2021

Feb 14, 2022

SELL
$20.7 - $34.18 $1.78 Million - $2.94 Million
-85,951 Reduced 42.34%
117,051 $3.42 Million
Q3 2021

Nov 15, 2021

BUY
$19.05 - $28.32 $516,578 - $767,953
27,117 Added 15.42%
203,002 $4.38 Million
Q2 2021

Aug 16, 2021

SELL
$18.93 - $25.65 $1.84 Million - $2.49 Million
-97,046 Reduced 35.56%
175,885 $4.51 Million
Q1 2021

May 14, 2021

SELL
$11.86 - $21.77 $1.77 Million - $3.25 Million
-149,481 Reduced 35.39%
272,931 $4.98 Million
Q4 2020

Feb 12, 2021

BUY
$7.25 - $11.76 $1.22 Million - $1.97 Million
167,601 Added 65.77%
422,412 $4.88 Million
Q3 2020

Nov 16, 2020

SELL
$6.53 - $8.6 $1.53 Million - $2.02 Million
-234,631 Reduced 47.94%
254,811 $1.94 Million
Q2 2020

Aug 14, 2020

BUY
$4.11 - $6.78 $816,763 - $1.35 Million
198,726 Added 68.36%
489,442 $3.21 Million
Q1 2020

May 15, 2020

BUY
$3.15 - $7.39 $242,408 - $568,697
76,955 Added 36.0%
290,716 $1.49 Million
Q4 2019

Feb 14, 2020

BUY
$5.01 - $8.16 $1.07 Million - $1.74 Million
213,761 New
213,761 $1.64 Million
Q3 2018

Nov 14, 2018

SELL
$4.28 - $7.32 $2.96 Million - $5.07 Million
-692,118 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$3.1 - $3.93 $5.96 Million - $7.56 Million
-1,923,244 Reduced 73.54%
692,118 $2.71 Million
Q1 2018

May 14, 2018

BUY
$2.32 - $4.22 $6.07 Million - $11 Million
2,615,362 New
2,615,362 $7.64 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $765M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.